(VIANEWS) - Dow Chemical Company (DOW), Avid Bioservices (CDMO), Evertec (EVTC) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Dow Chemical Company (DOW)
21.3% sales growth and 28.66% return on equity
Dow Inc. provides various materials science solutions for consumer care, infrastructure, and packaging markets in the United States, Canada, Europe, the Middle East, Africa, India, the Asia Pacific, and Latin America.
Dow Chemical Company's sales growth this year is anticipated to be 37.1% and a negative 3.1% for next year.
Year-on-year quarterly revenue growth grew by 66.2%, now sitting on 46.19B for the twelve trailing months.
Volume
Today's last reported volume for Dow Chemical Company is 3740860 which is 34.41% below its average volume of 5704010.
Dow Chemical Company's sales growth for the next quarter is 21.3%. The company's growth estimates for the present quarter and the next is 408% and 132.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 28.66%.
Volatility
Dow Chemical Company's last day, last week, and last month's current intraday variation average was 1.69%, 1.11%, and 1.34%, respectively.
Dow Chemical Company's highest amplitude of average volatility was 2.06% (day), 2.24% (last week), and 2.80% (last month), respectively.
Dow Chemical Company's Stock Yearly Top and Bottom Value
Dow Chemical Company's stock is valued at $61.86 at 05:22 EST, way below its 52-week high of $71.38 and way above its 52-week low of $50.20.
Dow Chemical Company's Moving Average
Dow Chemical Company's worth is above its 50-day moving average of $58.20 and under its 200-day moving average of $62.48.2. Avid Bioservices (CDMO)
20.7% sales growth and 27.91% return on equity
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture.
Avid Bioservices's sales growth this year is expected to be 21.8% and 29.5% for next year.
Year-on-year quarterly revenue growth grew by 24%, now sitting on 106.28M for the twelve trailing months.
Volume
Today's last reported volume for Avid Bioservices is 699992 which is 0.85% below its average volume of 706008.
Avid Bioservices's sales growth is a negative 0% for the present quarter and 20.7% for the next. The company's growth estimates for the current quarter and the next is 300% and 275%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 27.91%.
Volatility
Avid Bioservices's last day, last week, and last month's current intraday variation average was 4.81%, 3.18%, and 3.56%, respectively.
Avid Bioservices's highest amplitude of average volatility was 8.86% (day), 8.53% (last week), and 7.04% (last month), respectively.
Avid Bioservices's Stock Yearly Top and Bottom Value
Avid Bioservices's stock is valued at $17.43 at 05:22 EST, way under its 52-week high of $34.51 and way higher than its 52-week low of $14.87.
Avid Bioservices's Moving Average
Avid Bioservices's value is way below its 50-day moving average of $25.99 and way below its 200-day moving average of $24.61.3. Evertec (EVTC)
5.8% sales growth and 41.27% return on equity
EVERTEC, Inc. engages in transaction processing business serving financial institutions, merchants, corporations, and government agencies in Latin America and the Caribbean.
Evertec's sales growth this year is expected to be 13.7% and 5.7% for next year.
Year-on-year quarterly revenue growth grew by 6.9%, now sitting on 568.76M for the twelve trailing months.
Volume
Today's last reported volume for Evertec is 291709 which is 16.84% below its average volume of 350809.
Evertec's sales growth for the next quarter is 5.8%. The company's growth estimates for the present quarter and the next is 5.1% and 4.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 41.27%.
Volatility
Evertec's last day, last week, and last month's current intraday variation average was 1.17%, 2.11%, and 1.59%, respectively.
Evertec's highest amplitude of average volatility was 4.04% (day), 3.25% (last week), and 3.00% (last month), respectively.
Evertec's Stock Yearly Top and Bottom Value
Evertec's stock is valued at $42.27 at 05:22 EST, way below its 52-week high of $51.06 and way higher than its 52-week low of $35.51.